Antibiotic Susceptibility Testing Market to Raise at a CAGR of over 5.6% by 2028: Accelerate Diagnostics, Alifax, Liofilchem Srl, bioMérieux SA, and Merck KgaA
Growing use of antibiotics in treating even the most common health conditions remains a strong factor boosting demand for antibiotic susceptibility testing (AST). Increasing government funds for microbial and antibiotic susceptibility testing research and consistently improving outcome of PPPs in terms of enhanced screening and evaluation of antibiotics are playing a pivotal role in strengthening the performance of antibiotic susceptibility testing market. CDC's 'AMR Challenge' involving bioMérieux is a recently announced as objective to accelerate research efforts in the field of...
View full press release